<DOC>
	<DOCNO>NCT02639052</DOCNO>
	<brief_summary>The purpose study determine Botox effective treatment experimentally induce itch mimic chronic itch healthy volunteer .</brief_summary>
	<brief_title>Itch Relieving Effect Botox : Study Healthy Subjects</brief_title>
	<detailed_description>Several study show botulinum toxin type A ( BoNT/A ) antipruritic effect due inhibition acetylcholine pruritic factor , substance P glutamate . For instance , subcutaneous BoNT/A improve itch accompany hand eczema , dermatitis , lichen simplex , rhinitis . Furthermore , double-blind , placebo-controlled study show BoNT/A reduce histamine itch intensity healthy men . Since acetylcholine show mediate itch atopic dermatitis , study aim test itch relieve effect BoNT/A non-histaminergic model chronic itch . This non-histaminergic model use plant cowhage induces itch activate protease activate receptor 2 ( PAR2 ) receptor , play role itch atopic dermatitis , also make model well suit test efficacy BoNT/A relive chronic itch .</detailed_description>
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>1 . Healthy volunteer 18 50 year age . 2 . Must general good health disease physical condition would impair evaluation itch pain perception . 3 . No history chronic itch pain . 4 . Must abstain use systemic topical antihistamine , steroid , pain relief medication week prior study till completion study . 5 . Must abstain use moisturizers arm . 1 . Individuals 18 50 year age . 2 . Inability complete require measure . 3 . The presence itchy skin disease . 4 . Diagnosis diseased would affect itch pain perception ( e.g . neuropathy ) . 5 . Currently enrol investigational study subject receive type drug , biological , nondrug therapy . 6 . Use oral , topical analgesic , medication know interfere itch pain perception week prior study throughout study ( e.g . antihistamine , anesthetic , opioids , neuroleptic , etc. ) . 7 . Use emollient arm week prior study throughout study . 8 . Use antidepressant , antipsychotic , illicit drug . 9 . Known history neuropathy , uremia , uncontrolled thyroid disease , diabetes mellitus . 10 . Use Botulinum toxin last year . 11 . Known allergy Botox . 12 . Pregnant woman . ( Women child bear potential undergo human chorionic gonadotrophin ( hCG ) pregnancy test Botox application ) . 13 . Hypersensitivity botulinum toxin preparation component formulation . 14 . Infection injection site . 15 . Cardiovascular disease . 16 . Neuromuscular disorder ( e.g. , amyotrophic lateral sclerosis , myasthenia gravis , LambertEaton syndrome ) . 17 . Compromised respiratory function . 18 . Dysphagia . 19 . History urinary tract infection . 20 . History urinary retention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Itch</keyword>
	<keyword>Botox</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>